Identification of an AKT-dependent signalling pathway that mediates tamoxifen-dependent induction of the pro-metastatic protein anterior gradient-2

Hrstka, Roman; Murray, Euan; Brychtova, Veronika; Fabian, Pavel; Hupp, Ted R.; Vojtesek, Borivoj

Identification of an AKT-dependent signalling pathway that mediates tamoxifen-dependent induction of the pro-metastatic protein anterior gradient-2

2013

The pro-metastatic protein anterior gradient-2 (AGR2) was previously demonstrated as a predictive factor of poor response to tamoxifen treatment. In this study we aimed to delineate the key signalling pathway that may contribute to regulation of AGR2 protein induction in order to identify novel targets to overcome tamoxifen resistance in tumour cells. Together, our data identify PDPK1-AKT as a pro-oncogenic signalling pathway that triggers AGR2 protein induction in response to tamoxifen and suggest that AKT inhibitors could be used as part of a therapeutic strategy to treat tamoxifen resistant, AGR2 over-expressing cancers.

Mostrar más [+]

Palabras clave de AGROVOC

antineoplastic agents drug resistance drug therapy genetics humans metabolism neoplasms pathology pharmacology proteins proteins ribonucleosides serine

Información bibliográfica

Publicado en

Cancer letters

ISSN 0304-3835

Editorial

Elsevier B.V.

Otras materias

Drug effects; Proto-oncogene proteins c-akt; Cell line; Tumor; Base sequence; Micrornas; Signal transduction; 3-phosphoinositide-dependent protein kinases; Breast neoplasms; Tamoxifen; Protein serine-threonine kinases; Molecular sequence data; Female; Tamoxifen; Hormonal; Signal transduction

Idioma

Inglés

Tipo

Journal Article; Text

En AGRIS desde: 2024-02-27

Formato: MODS

Proveedor de Datos

Este registro bibliográfico ha sido proporcionado por National Agricultural Library

Descubra la colección de este proveedor de datos en AGRIS

Enlaces

DOI http://dx.doi.org/10.1016/j.canlet.2013.01.034

Buscar en Google Scholar